1Lyden PD, Grotta JC, Levine SR, et al. Intravenous thrombolysis for acute stroke. Neurology, 1997,49:14.
2del Zoppo GJ,Higashida RT,Furlan AJ,et al. and the Proact Investigators: Procat. A phase Ⅱ randomized trial of recombinant prourokinase by direct arterial delivery in acute middle cerebnd artery stroke. Stroke, 1998,29:4.
3GROTTA J C, WELCH K M A, FAGAN S C, et al. Clinical deterioration following improvement in the NINDS rt-PA stroke trial[J]. Stroke, 2001, 32(3):661-668.
4LYDEN P, LU M, KWIATKOWSKI T, et al. Thrombolysis in patients with transient neurologic deficits[J]. Neurology,2001, 57(23): 2125-2128.
5del ZOPPO G J, HIGASHIDA R T, FURLAN A J, et al.PROACT: a phase 11 randomized trail of recombinant prourokinase by direct arterial delivery in acute middle cerebral artery stroke[J]. Stroke, 1998, 29(1): 4-11.
6LARRUE V, yon KUMMER R, MULLER A, et al. Risk factors for serve hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator:a secondary analysis of the European-Australasian Acute Stroke Study[J]. Stroke, 2001, 32(2): 438-441.
7The NINDS t-PA Stroke Study Group.Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke[J]. Stroke, 1997, 28 (11): 2109-2118.
8ZAIDAT O O, SUAREZ J I. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion [J].Stroke, 2002, 33(7): 1821-1827.
5Bi M, Ma Q, Zhang S, et al. Local mild hypothermia with throm- bolysis for acut isehemic stroke within a 6-h window[J]. Clin NeurolNeurosurg, 2011, 113(9): 768-773.
7Amenta PS, Ali MS, Dumont AS, et al. Computed tomogmphy perfusion-based selection of patients for endovascular recanaliza- tion[J]. Neurosurg Focus, 2011, 30(6):E6.
8Josephson SA, Saver JL, Smith WS. Comparison of mechanical embolectomy and intraarterial thrombolysis in acute ischemic stroke within the MCA: MERCI and Multi MERCI compared to PROACT ]I [J]. Neurocrit Care, 2009, 10(1): 43-49.
